Published in ORL J Otorhinolaryngol Relat Spec on January 01, 1982
An updated overview of HPV-associated head and neck carcinomas. Oncotarget (2014) 1.06
Skull base inverted papilloma: a comprehensive review. ISRN Surg (2012) 0.96
Human papilloma virus infection in head and neck cancer. Dtsch Arztebl Int (2013) 0.81
Molecular characterization of late stomal recurrence following total laryngectomy. Oncol Rep (2011) 0.79
Human papillomavirus 16 infection predicts poor outcome in patients with esophageal squamous cell carcinoma. Onco Targets Ther (2015) 0.76
HPV16 E6-E7 induces cancer stem-like cells phenotypes in esophageal squamous cell carcinoma through the activation of PI3K/Akt signaling pathway in vitro and in vivo. Oncotarget (2016) 0.75
Recent advances in managing human papillomavirus-positive oropharyngeal tumors. F1000 Med Rep (2010) 0.75
Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet (1998) 5.65
Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology (2000) 3.94
Response to doxorubicin/methotrexate/fluorouracil in advanced adenocarcinoma of pancreas or biliary tract. Lancet (1990) 2.22
Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer (1992) 1.96
Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol (1995) 1.85
Regression of warts. An immunological study. Lancet (1975) 1.78
Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer (1994) 1.76
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus. Proc Natl Acad Sci U S A (2000) 1.66
Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg (1983) 1.65
Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer (1993) 1.63
Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis (1994) 1.61
Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer (2000) 1.59
Sensitivity of in situ hybridization techniques using biotin- and 35S-labeled human papillomavirus (HPV) DNA probes. J Virol Methods (1988) 1.58
Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. Hum Mol Genet (1997) 1.53
Endometriosis-associated ovarian carcinoma (EAOC): an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol (2001) 1.52
Tamoxifen and toremifene lower serum cholesterol by inhibition of delta 8-cholesterol conversion to lathosterol in women with breast cancer. J Clin Oncol (1995) 1.50
A low proportion of BRCA2 mutations in Finnish breast cancer families. Am J Hum Genet (1997) 1.46
Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease. Prenat Diagn (1996) 1.46
Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer (2009) 1.44
Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer. Acta Cytol (2000) 1.41
Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer (1994) 1.40
Wart-virus antibodies and the prognosis of wart disease. Lancet (1972) 1.36
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol (1983) 1.31
Transgenic mice aberrantly expressing human ornithine decarboxylase gene. J Biol Chem (1991) 1.29
Enhanced expression of the tie receptor tyrosine kinase mesenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res (1994) 1.28
Expression of E-cadherin (E-CD) as related to other prognostic factors and survival in breast cancer. J Pathol (1994) 1.27
Natural history of cervical human papillomavirus lesions does not substantiate the biologic relevance of the Bethesda System. Obstet Gynecol (1992) 1.26
Diagnosis of genital human papillomavirus (HPV) lesions in the male: correlation of peniscopy, histology and in situ hybridisation. Genitourin Med (1993) 1.23
The acetic acid test in evaluation of subclinical genital papillomavirus infection: a comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings. Genitourin Med (1992) 1.21
Report on consensus conference on cervical cancer screening and management. Int J Cancer (2000) 1.20
Prospective follow-up of cervical HPV infections: life table analysis of histopathological, cytological and colposcopic data. Eur J Epidemiol (1989) 1.20
Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies. Arch Gynecol (1986) 1.20
Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol (1996) 1.17
Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up. Int J STD AIDS (2003) 1.17
Immunohistochemical demonstration of human papilloma virus (HPV) antigens in oral squamous cell lesions. Br J Oral Surg (1983) 1.17
Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. Sex Transm Dis (1990) 1.17
Tumourigenesis associated with the p53 tumour suppressor gene. Br J Cancer (1993) 1.16
Survival of breast cancer patients in BRCA1, BRCA2, and non-BRCA1/2 breast cancer families: a relative survival analysis from Finland. Int J Cancer (2001) 1.15
Squamous cell carcinoma of the conjunctiva. Failure to demonstrate HPV DNA by in situ hybridization and polymerase chain reaction. Acta Ophthalmol (Copenh) (1992) 1.14
HIV antibodies in whole saliva detected by ELISA and western blot assays. J Med Virol (1990) 1.14
Cervical papillomavirus infection progressing to invasive cancer in less than three years. Lancet (1985) 1.13
Analysis of G(1)/S checkpoint regulators in metastatic melanoma. Genes Chromosomes Cancer (2000) 1.13
Comparison of cell proliferation and toxicity assays using two cationic liposomes. Pharm Res (1994) 1.13
Hormone receptors as prognostic factors in female breast cancer. Ann Med (1991) 1.12
Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression. Melanoma Res (1999) 1.11
Screening for metastatic malignant melanoma of the uvea revisited. Cancer (1999) 1.10
An improved in situ DNA hybridization protocol for detection of human papillomavirus (HPV) DNA sequences in paraffin-embedded biopsies. J Virol Methods (1986) 1.10
Infectious agents in the etiology of esophageal cancer. Gastroenterology (1992) 1.10
Letter: Negative complement-fixation tests as an immunopathological finding. Lancet (1974) 1.10
Malignant fibrous histiocytoma of the vulva. Gynecol Oncol (1987) 1.10
Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study. J Clin Oncol (1992) 1.10
Risk factors associated with cervical human papillomavirus infections: a case-control study. Am J Epidemiol (1993) 1.10
Natural history of cervical human papillomavirus (HPV) infections based on prospective follow-up. Br J Obstet Gynaecol (1985) 1.09
Expression of transcription factor AP-2alpha predicts survival in epithelial ovarian cancer. Br J Cancer (2000) 1.09
The important prognostic value of Ki-67 expression as determined by image analysis in breast cancer. J Cancer Res Clin Oncol (1996) 1.08
Cancer of the tongue in patients younger than 40 years. A distinct entity? Arch Otolaryngol Head Neck Surg (1996) 1.07
Herpes simplex virus type 1 infection has two separate modes of spread in three-dimensional keratinocyte culture. J Gen Virol (1999) 1.05
Sexual behaviour of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis (1984) 1.05
Clinical significance of alpha-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer. J Clin Oncol (1998) 1.05
Low concordance of genital human papillomavirus (HPV) lesions and viral types in HPV-infected women and their male sexual partners. Sex Transm Dis (1997) 1.05
Prognostic factors in cervical human papillomavirus infections. Sex Transm Dis (1992) 1.05
Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis. Br J Cancer (1994) 1.04
Hunan wart-virus antibodies in patients with genital and skin warts. Acta Derm Venereol (1978) 1.04
Failure to demonstrate human papillomavirus DNA in epithelial ovarian cancer by general primer PCR. Gynecol Oncol (1999) 1.04
Diploid predominance in hereditary nonpolyposis colorectal carcinoma evaluated by flow cytometry. Cancer (1990) 1.03
Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of peniscopy. Genitourin Med (1991) 1.02
Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol (1995) 1.02
An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer (1999) 1.02
Elevated CA19-9 as the most significant prognostic factor in advanced colorectal carcinoma. J Surg Oncol (1992) 1.02
Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland). Cancer Causes Control (2001) 1.01
Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. Eur J Cancer (2003) 1.01
Cytokeratin expression patterns as an indicator of tumour progression in oesophageal squamous cell carcinoma. Anticancer Res (2002) 1.01